Search results for "Chronic kidney disease"
GLP-1 receptor agonists may offer kidney protection in patients with type 2 diabetes
An industry-conducted pooled analysis of two large trials of glucagon-like peptide-1 (GLP-1) receptor agonists found that both semaglutide and liraglutide slowed kidney function decline, with semaglutide appearing to have the greatest effect.
https://immattersacp.org/weekly/archives/2021/12/21/2.htm
21 Dec 2021
Diagnosis at 10 paces for bitemporal wasting
In a new series, Pearls from I.M. Peers, Paul Dallas, MD, MACP, explains how making a simple observation in a patient could indicate a serious diagnosis.
https://immattersacp.org/archives/2022/01/diagnosis-at-10-paces-for-bitemporal-wasting.htm
1 Jan 2022
Improving HCV treatment and screening in primary care
Amid global calls to eliminate viral hepatitis, efforts are underway to screen asymptomatic adults for hepatitis C and overcome barriers to treatment.
https://immattersacp.org/archives/2022/01/improving-hcv-treatment-and-screening-in-primary-care.htm
1 Jan 2022
Equation for kidney failure risk that excludes race shows better sensitivity, specificity than eGFR alone
The four-variable equation includes age, sex, estimated glomerular filtration rate (eGFR), and urinary albumin-creatinine ratio.
https://immattersacp.org/weekly/archives/2022/01/11/4.htm
11 Jan 2022
Allopurinol not associated with increased mortality in patients with CKD, gout
The findings of a database analysis from the United Kingdom provide reassurance that a treat-to-target strategy has no apparent harmful effect on mortality in patients with gout and chronic kidney disease (CKD).
https://immattersacp.org/weekly/archives/2022/01/25/2.htm
25 Jan 2022
MKSAP Quiz: Follow-up for microscopic hematuria
A 35-year-old woman is evaluated during a follow-up visit for recurrent microscopic hematuria without proteinuria. Following a physical exam, lab studies, and kidney ultrasound, what is the most likely diagnosis?
https://immattersacp.org/weekly/archives/2022/03/08/3.htm
8 Mar 2022
Factoring drug costs into diabetes decisions
A sizable number of patients with diabetes do not consistently fill their prescriptions or take less than the prescribed amount due to costs, but there are ways to make it easier on a patient's pocketbook.
https://immattersacp.org/archives/2022/05/factoring-drug-costs-into-diabetes-decisions.htm
1 May 2022
Post-COVID-19 clinic director offers tips on lingering symptoms
The first step to treating patients with postacute sequelae of SARS-CoV-2 (PASC) is simple, one expert said: Believe them.
https://immattersacp.org/archives/2022/06/post-covid-19-clinic-director-offers-tips-on-lingering-symptoms.htm
1 Jun 2022
Diltiazem may increase bleeding risk when coadministered with DOACs in afib
A study of patients with atrial fibrillation in one U.S. health system found a 56% higher risk for bleeding-related hospitalization associated with concomitant use of diltiazem and a direct-acting oral anticoagulant (DOAC) versus a DOAC alone.
https://immattersacp.org/weekly/archives/2022/07/12/5.htm
12 Jul 2022
New trials provide data to improve medication management in hypertension
A U.K. study compared morning versus evening dosing of antihypertensive drugs, a U.S. study looked at optimal dosing in patients with proteinuria, and a trial in Spain tested self-titration in patients with poorly controlled hypertension.
https://immattersacp.org/weekly/archives/2022/10/18/6.htm
18 Oct 2022